Marker Therapeutics (MRKR) Misses Q3 EPS by 26c
Tweet
Share
E-mailGet Alerts MRKR Hot Sheet
Join SI Premium – FREE
Marker Therapeutics (NASDAQ: MRKR) reported Q3 EPS of ($0.26). Revenue for the quarter came in at $1.93 million.
For earnings history and earnings-related data on Marker Therapeutics (MRKR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Subaru, other Japan suppliers to team on delivery as Boeing raises output - Nikkei
- Toro Company (TTC) Tops Q3 EPS by 3c; offers guidance
- Victoria's Secret & Co. (VSXY) Tops Q2 EPS by 20c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
